EU Reviews J&J Clot Link, Widens AstraZeneca Probe
Umer Jamshaid Published April 09, 2021 | 07:36 PM
The EU's drug regulator said Friday it is reviewing possible blood clot cases in people given the Johnson & Johnson coronavirus shot and probing a new condition linked to the AstraZeneca vaccine
The Hague, (APP - UrduPoint / Pakistan Point News - 9th Apr, 2021 ) :The EU's drug regulator said Friday it is reviewing possible blood clot cases in people given the Johnson & Johnson coronavirus shot and probing a new condition linked to the AstraZeneca vaccine.
Four cases, one fatal, of rare clots with low blood platelets were reported among those vaccinated with the Johnson & Johnson shot, the European Medicines Agency (EMA) said in a statement.
Five cases meanwhile were reported of people suffering a rare condition in which tiny blood vessels leak after getting the AstraZeneca jab, causing swelling and a drop in blood pressure.
"It is not yet clear whether there is a causal association" between the two vaccines and the cases, the Amsterdam-based EMA said in a statement.
The fresh questions over vaccine safety come after the watchdog said Wednesday it was listing blood clots as a very rare side effect of the shot by British-Swedish firm AstraZeneca.
But the EMA said its safety committee had now turned its attention to US pharma giant Johnson & Johnson, and "started a review of a safety signal to assess reports of thromboembolic events" in people who had received the jab.
"One case occurred in a clinical trial and three cases occurred during the vaccine rollout in the USA.
One of them was fatal," it said.
The EMA has already approved the Johnson & Johnson vaccine for use, but its rollout across the 27-nation EU is not due to start until later this month.
The EMA safety committee has also started reviewing "reports of capillary leak syndrome" in people in Europe who have received the AstraZeneca vaccination.
"Five cases of this very rare disorder, characterised by leakage of fluid from blood vessels causing tissue swelling and a drop in blood pressure, were reported," it said.
Both the Johnson & Johnson and AstraZeneca jabs use similar adenovirus vector technology.
The EMA said that after investigating both of the new reports it would "decide whether regulatory action may be necessary", which usually involves adding a notification about side effects.
The EMA said earlier this week that it was aware of cases linked to the J&J vaccine, but gave a lower number of three and did not mention the death.
The overall numbers were "extremely small" compared to the 4.5 million Johnson & Johnson shots administered worldwide, EMA safety chief Peter Arlett told a press conference on Wednesday.
"This is however under close scrutiny... I think it is fair to say there is intensive monitoring of this issue across the vaccines," Arlett said.
Related Topics
Recent Stories
Selection committee dissolved over Pakistan women cricket team's poor performanc ..
Punjab CM Maryam Nawaz in police uniform at Chung police center
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 25 April 2024
Today Gold Rate in Pakistan 25 April 2024
Mired in crisis, Boeing reports another loss
Session Awarding Ceremony 2024 held at Cadet College Muzaffarabad
Austrian ski great Hirscher to make comeback under Dutch flag
Pakistan, Japan agrees to convene 'Economic Policy Dialogue'
FM Dar conveys deepest sympathy on torrential rains devastation in UAE
Spain PM Sanchez says weighing resignation after wife's graft probe
Tennis: ATP/WTA Madrid Open results - 1st update
Long-lost Klimt portrait auctioned off for 30 mn euros
More Stories From World
-
Car giants vie for EV crown at Beijing's Auto China show
8 minutes ago -
Blades of Paris landmark Moulin Rouge windmill collapse
17 minutes ago -
Advanced 5G base station launched in Mt. Qomolangma
18 minutes ago -
China committed to supporting Zimbabwe's innovation-driven development
28 minutes ago -
Myanmar to hold 59th gems emporium next month
57 minutes ago -
Digital economy contributes 8.4 pct to Philippine economy in 2023
58 minutes ago
-
China committed to supporting Zimbabwe's innovation-driven development
58 minutes ago -
Starfish control program improving health of Australia's Great Barrier Reef: report
58 minutes ago -
Pakistan calls for addressing development changes at a key UN meeting
1 hour ago -
Advanced 5G base station launched in Mt. Qomolangma
1 hour ago -
Cambodia on right track to achieving malaria-free goal by 2025: PM
1 hour ago -
Endrick sparks Palmeiras comeback in Copa Libertadores
1 hour ago